LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 18.98 | 27.76 | 108 | 941 | 0.1148 | 0.3064 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 18.98 | 27.76 | 819 | 941 | 0.8702 | 0.9461 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 20.68 | 27.76 | 1090 | 1119 | 0.9741 | 0.9902 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 20.68 | 27.76 | 1144 | 1119 | 1.0223 | 1.0083 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 20.68 | 27.76 | 123 | 1119 | 0.1099 | 0.3220 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 20.68 | 27.76 | 1014 | 1119 | 0.9062 | 0.9634 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 22.39 | 27.76 | 1205 | 1305 | 0.9229 | 0.9713 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 22.39 | 27.76 | 1239 | 1305 | 0.9489 | 0.9812 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 22.39 | 27.76 | 142 | 1305 | 0.1088 | 0.3415 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 22.39 | 27.76 | 841 | 1305 | 0.6441 | 0.8477 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 24.09 | 27.76 | 1209 | 1461 | 0.8272 | 0.9347 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 24.09 | 27.76 | 1242 | 1461 | 0.8497 | 0.9439 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 24.09 | 27.76 | 151 | 1461 | 0.1033 | 0.3447 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 24.09 | 27.76 | 1011 | 1461 | 0.6917 | 0.8752 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 25.79 | 27.76 | 1343 | 1605 | 0.8367 | 0.9400 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 25.79 | 27.76 | 1370 | 1605 | 0.8535 | 0.9466 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 25.79 | 27.76 | 192 | 1605 | 0.1196 | 0.3915 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 25.79 | 27.76 | 1260 | 1605 | 0.7850 | 0.9190 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 27.49 | 27.76 | 1402 | 1723 | 0.8136 | 0.9319 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 27.49 | 27.76 | 1430 | 1723 | 0.8299 | 0.9384 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 27.49 | 27.76 | 225 | 1723 | 0.1306 | 0.4210 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 27.49 | 27.76 | 1589 | 1723 | 0.9222 | 0.9730 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 29.19 | 27.76 | 1469 | 1863 | 0.7885 | 0.9232 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 29.19 | 27.76 | 1497 | 1863 | 0.8035 | 0.9292 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 29.19 | 27.76 | 266 | 1863 | 0.1428 | 0.4512 | MN20160318_Q01 | M17 |